Brown Hilary K, McKnight Anthony, Aker Amira
Department of Health & Society, University of Toronto Scarborough, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
J Multimorb Comorb. 2022 Apr 30;12:26335565221096584. doi: 10.1177/26335565221096584. eCollection 2022.
We reviewed the literature on the association between pre-pregnancy multimorbidity (co-occurrence of two or more chronic conditions) and adverse maternal outcomes in pregnancy and postpartum.
Medline, EMBASE, and CINAHL were searched from inception to September, 2021.
Observational studies were eligible if they reported on the association between ≥ 2 co-occurring chronic conditions diagnosed before conception and any adverse maternal outcome in pregnancy or within 365 days of childbirth, had a comparison group, were peer-reviewed, and were written in English.
Two reviewers used standardized instruments to extract data and rate study quality and the certainty of evidence. A narrative synthesis was performed.
Of 6,381 studies retrieved, seven met our criteria. There were two prospective cohort studies, two retrospective cohort studies, and 3 cross-sectional studies, conducted in the United States (n=6) and Canada (n=1), and ranging in size from n=3,110 to n=57,326,681. Studies showed a dose-response relation between the number of co-occurring chronic conditions and risk of adverse maternal outcomes, including severe maternal morbidity or mortality, hypertensive disorders of pregnancy, and acute health care use in the perinatal period. Study quality was rated as strong (n=1), moderate (n=4), or weak (n=2), and the certainty of evidence was very low to moderate.
Given the increasing prevalence of chronic disease risk factors such as advanced maternal age and obesity, more research is needed to understand the impact of pre-pregnancy multimorbidity on maternal health so that appropriate preconception and perinatal supports can be developed.
我们回顾了关于孕前多种疾病(两种或更多种慢性病同时存在)与妊娠及产后不良孕产妇结局之间关联的文献。
检索了Medline、EMBASE和CINAHL数据库,检索时间从建库至2021年9月。
如果观察性研究报告了受孕前诊断出的≥2种同时存在的慢性病与妊娠期间或分娩后365天内的任何不良孕产妇结局之间的关联,有对照组,经过同行评审且为英文撰写,则该研究符合入选标准。
两名评审员使用标准化工具提取数据并对研究质量和证据的确定性进行评分。进行了叙述性综合分析。
在检索到的6381项研究中,有7项符合我们的标准。其中有两项前瞻性队列研究、两项回顾性队列研究和3项横断面研究,这些研究在美国(n = 6)和加拿大(n = 1)开展,样本量从n = 3110到n = 57326681不等。研究表明,同时存在的慢性病数量与不良孕产妇结局的风险之间存在剂量反应关系,这些不良结局包括严重孕产妇发病或死亡、妊娠高血压疾病以及围产期急性医疗保健的使用。研究质量被评为强(n = 1)、中(n = 4)或弱(n = 2),证据的确定性为非常低到中等。
鉴于高龄孕产妇和肥胖等慢性病风险因素的患病率不断上升,需要更多研究来了解孕前多种疾病对孕产妇健康的影响,以便制定适当的孕前和围产期支持措施。